Company Directory / research
PrivateFor profitresearchJette, Belgium
Precirix
Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.
- Founded
- 2014 12 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $117M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
12 years old.
Reach
Website ranked #7,873,553 in the world for traffic, about 680 visits a month.
What it does
BiotechnologyHealth Care
Funding, as listed
$117M currency not stated
- Rounds2
- LatestSeries b, Mar 2022
- Investors9, 5 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Precirix, field by field. Contact details are held but never shown.
The company
- Name
- Precirix
- Type
- For profit
- Status
- Private
- Founded
- 2014
- Founders
- Geert Raes, Jens De Vos, Ludwig Camusot, Matthias D'Huyvetter, Nick Devoogdt
- Industry
- research
- Categories
- Biotechnology, Health Care
Where
- City
- Jette
- Country
- Belgium
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #7,873,553
- Monthly web visits
- 680
Funding, as listed
- Total
- 117,000,000 (currency not stated)
- Rounds
- 2
- Latest round
- Series b
- Latest round date
- Mar 2022
- Investors
- 9
- Lead investors
- 5
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Companies like it
research in Belgium.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 36,920 companies in Belgium and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.